课题基金 / 基金详情

ROLE OF MICRORNAS IN THE MOLECULAR PATHOGENESIS OF HIV/SIV ENTEROPATHY

ROLE OF MICRORNAS IN THE MOLECULAR PATHOGENESIS OF HIV/SIV ENTEROPATHY
微生物在 HIV/SIV 肠病分子发病机制中的作用
批准号:
8358100
负责人:
Mahesh Mohan
金额:
$4.52万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30

项目摘要

项目成果

Mahesh Mohan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The Gastrointestinal tract (GIT) is a major target of HIV/SIV infection. Although our understanding of HIV/SIV enteropathy has greatly improved, the recent discovery of miRNAs has added yet another novel and complex regulator of gene expression with potential roles in the molecular pathogenesis of this disorder. microRNAs (miRNAs) are genomically transcribed, ~21-23 nucleotide noncoding RNAs that are highly conserved and suppress gene expression by targeting mRNAs for translational repression or degradation. We investigated the contribution of miRNAs to GIT disease and inflammation using the SIV-infected rhesus macaque model. Colon tissue was collected at necropsy from 8 acutely SIV-infected (G1) (n=3, 8 days post SIV infection and n=5, 13-30 days post SIV infection) and 5 uninfected control macaques (G2). The contribution of miRNAs to GIT disease and inflammation was investigated using TaqMan Low Density Array (TLDA), QRT-PCR, In situ hybridization/Immunofluorescence and histopathology. Approximately 70% of the 377 miRNAs on card A and 50% of the 377 miRNAs on card B cross-reacted with the rhesus macaque. Following data analysis using STATMINER we identified a total of 25 card A and 12 card B miRNAs to be differentially expressed (p 0.05) in response to SIV infection. Important differentially expressed card A miRNAs included miR-1, -26a, -29c, -34a, -125b, -126, -130a, -133b, -135a, -140-5p, -let7b, -let7c, -222, -224, -383. Similarly, notable differentially expressed card B miRNAs included -190b, -550, -1247. QRT-PCR to further confirm TLDA expression profiles and in situ hybridization studies to identify specific cell types expressing these miRNAs are currently in progress. Our findings suggest that deregulation in cell/tissue-specific expression of miRNAs occurring in response to HIV/SIV infection may disrupt the functional relationship between the intestinal epithelium and the mucosal immune system causing alterations in intestinal structure and function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cannabinoid modulation of EV composition and function in HIV/SIV infection
  • 批准号:
    10693315
  • 项目类别:
  • 资助金额:
    $78.47万
  • 财政年份:
    2022
  • 负责人:
    Mahesh Mohan
  • 依托单位:
Cannabinoid modulation of EV composition and function in HIV/SIV infection
  • 批准号:
    10662831
  • 项目类别:
  • 资助金额:
    $77.6万
  • 财政年份:
    2022
  • 负责人:
    Mahesh Mohan
  • 依托单位:
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.
  • 批准号:
    10664337
  • 项目类别:
  • 资助金额:
    $21.8万
  • 财政年份:
    2021
  • 负责人:
    Mahesh Mohan
  • 依托单位:
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.
  • 批准号:
    10842560
  • 项目类别:
  • 资助金额:
    $44.06万
  • 财政年份:
    2021
  • 负责人:
    Mahesh Mohan
  • 依托单位:
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: